FibroScan®: Painless, Accurate, Noninvasive Way to Assess Liver Health
GANJ, a leader in healthcare management, now offers FibroScan® to assess liver health and support early detection and management of liver disease.
Liver disease, such as nonalcoholic fatty liver disease (NAFLD), is associated with obesity, insulin resistance, diabetes and other metabolic risk factors. One in three Americans have liver disease.
Maintaining good liver health is important to your overall health. That’s why physicians at ((NAME OF PRACTICE)) use FDA-approved FibroScan®:
FibroScan: How it works